Popp D, Holmes K C
Max Planck Institut fuer medizinische Forschung, Abteilung Biophysik, Heidelberg, Deutschland.
J Mol Biol. 1992 Mar 5;224(1):65-76. doi: 10.1016/0022-2836(92)90576-6.
The ATPase activity of acto-myosin subfragment 1 (S1) at low ratios of S1 to actin in the presence of tropomyosin is dependent on the tropomyosin source and ionic conditions. Whereas skeletal muscle tropomyosin causes a 60% inhibitory effect at all ionic strengths, the effect of smooth muscle tropomyosin was found to be dependent on the ionic strength. At low ionic strength (20 mM) smooth muscle tropomyosin inhibits the ATPase activity by 60%, while at high ionic strength (120 mM) it potentiates the ATPase activity three- to five-fold. Therefore, the difference in the effect of smooth muscle and skeletal muscle tropomyosin on the acto-S1 ATPase activity was due to a greater fraction of the tropomyosin-actin complex being turned on in the absence of S1 with smooth muscle tropomyosin than with skeletal muscle tropomyosin. Using well-oriented gels of actin and of reconstituted specimens from vertebrate smooth muscle thin filament proteins suitable for X-ray diffraction, we localized the position of tropomyosin on actin under different levels of acto-S1 ATPase activity. By analysing the equatorial X-ray pattern of the oriented specimens in combination with solution scattering experiments, we conclude that tropomyosin is located at a binding radius of about 3.5 nm on the f-actin helix under all conditions studied. Furthermore, we find no evidence that the azimuthal position of tropomyosin is different for smooth muscle tropomyosin at various ionic strengths, or vertebrate tropomyosin, since the second actin layer-line intensity (at 17.9 nm axial and 4.3 nm radial spacing), which was shown in skeletal muscle to be a sensitive measure of this parameter, remains strong and unchanged. Differences in the ATPase activity are not necessarily correlated with different positions of tropomyosin on f-actin. The same conclusion is drawn from our observations that, although the regulatory protein caldesmon inhibits the ATPase activity in native and reconstituted vertebrate smooth muscle thin filaments at a molar ratio of actin/tropomyosin/caldesmon of 28:7:1, the second actin layer-line remains strong. Only adding caldesmon in excess reduces the intensity of the second actin layer-line, from which the binding radius of caldesmon can be estimated to be about 4 nm. The lack of predominant meridional reflections in oriented specimens, with caldesmon present, suggests that caldesmon does not project away from the thin filament as troponin molecules in vertebrate striated muscle in agreement with electron micrographs of smooth muscle thin filaments. In freshly prepared native smooth muscle thin filaments we observed a Ca(2+)-sensitive reversible bundling effect.(ABSTRACT TRUNCATED AT 400 WORDS)
在原肌球蛋白存在的情况下,肌动蛋白-肌球蛋白亚片段1(S1)在低S1与肌动蛋白比例时的ATP酶活性取决于原肌球蛋白来源和离子条件。骨骼肌原肌球蛋白在所有离子强度下均产生60%的抑制作用,而平滑肌原肌球蛋白的作用则取决于离子强度。在低离子强度(20 mM)时,平滑肌原肌球蛋白抑制ATP酶活性60%,而在高离子强度(120 mM)时,它使ATP酶活性增强三到五倍。因此,平滑肌和骨骼肌原肌球蛋白对肌动蛋白-S1 ATP酶活性影响的差异是由于在没有S1的情况下,与骨骼肌原肌球蛋白相比,平滑肌原肌球蛋白形成的原肌球蛋白-肌动蛋白复合物有更大比例处于激活状态。利用适合X射线衍射的肌动蛋白以及来自脊椎动物平滑肌细肌丝蛋白重构标本的取向良好的凝胶,我们在不同水平的肌动蛋白-S1 ATP酶活性下确定了原肌球蛋白在肌动蛋白上的位置。通过结合溶液散射实验分析取向标本的赤道X射线图谱,我们得出结论,在所有研究条件下,原肌球蛋白位于f-肌动蛋白螺旋上约3.5 nm的结合半径处。此外,我们没有发现证据表明在不同离子强度下平滑肌原肌球蛋白或脊椎动物原肌球蛋白的原肌球蛋白方位位置存在差异,因为在骨骼肌中显示对该参数敏感的第二个肌动蛋白层线强度(轴向17.9 nm和径向间距4.3 nm)仍然很强且不变。ATP酶活性的差异不一定与原肌球蛋白在f-肌动蛋白上的不同位置相关。我们的观察也得出了相同的结论,即尽管调节蛋白钙调蛋白在肌动蛋白/原肌球蛋白/钙调蛋白摩尔比为28:7:1时抑制天然和重构的脊椎动物平滑肌细肌丝中的ATP酶活性,但第二个肌动蛋白层线仍然很强。只有过量添加钙调蛋白才会降低第二个肌动蛋白层线的强度,由此可估计钙调蛋白的结合半径约为4 nm。在存在钙调蛋白的取向标本中缺乏主要的子午线反射,这表明钙调蛋白不像脊椎动物横纹肌中的肌钙蛋白分子那样从细肌丝伸出,这与平滑肌细肌丝的电子显微镜图像一致。在新鲜制备的天然平滑肌细肌丝中,我们观察到了一种Ca(2+)敏感的可逆成束效应。(摘要截选至400字)